Rediffmail Money rediffGURUS BusinessEmail

Cipla to acquire two US-based pharma cos for $550 million

September 04, 2015 10:23 IST
By Zeba Siddiqui

Cipla Ltd, India's fourth-largest drugmaker by sales, said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deal worth $550 million to get access to a wide range of products.

The companies to be acquired, InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc, had combined sales of $225 million in the last twelve months to June 2015, Cipla said in a statement. 

Zeba Siddiqui
Source: REUTERS
© Copyright 2025 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

More News Coverage

Cipla InvaGen Pharmaceuticals Inc Exelan Pharmaceuticals Inc United States US

RELATED STORIES

WEB STORIES

India's 10 Longest Sacred Rivers

12 More Exciting Recipes For Your Lunchbox

9 Best Countries To Raise Your Kids

VIDEOS